• Je něco špatně v tomto záznamu ?

Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation

O. Jandourek, M. Tauchman, P. Paterova, K. Konecna, L. Navratilova, V. Kubicek, O. Holas, J. Zitko, M. Dolezal,

. 2017 ; 22 (2) : . [pub] 20170202

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023315

Aminodehalogenation of 3-chloropyrazine-2-carboxamide with variously substituted benzylamines yielded a series of fifteen 3-benzylaminopyrazine-2-carboxamides. Four compounds possessed in vitro whole cell activity against Mycobacterium tuberculosis H37Rv that was at least equivalent to that of the standard pyrazinamide. MIC values ranged from 6 to 42 μM. The best MIC (6 μM) was displayed by 3-[(4-methylbenzyl)amino]pyrazine-2-carboxamide (8) that also showed low cytotoxicity in the HepG2 cell line (IC50 ≥ 250 μM). Only moderate activity against Enterococcus faecalis and Staphylococcus aureus was observed. No activity was detected against any of tested fungal strains. Molecular docking with mycobacterial enoyl-ACP reductase (InhA) was performed to investigate the possible target of the prepared compounds. Active compounds shared common binding interactions of known InhAinhibitors. Antimycobacterial activity of the title compounds was compared to the previously published benzylamino-substituted pyrazines with differing substitution on the pyrazine core (carbonitrile moiety). The title series possessed comparable activity and lower cytotoxicity than molecules containing a carbonitrile group on the pyrazine ring.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023315
003      
CZ-PrNML
005      
20170720124149.0
007      
ta
008      
170720s2017 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/molecules22020223 $2 doi
035    __
$a (PubMed)28157178
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jandourek, Ondrej $u Department of Biological and Medical Sciences, Teaching and Research Center of Charles University, Faculty of Pharmacy in Hradec Kralove, Charles University, Zborovska 2089, Hradec Kralove 50003, Czech Republic. jando6aa@faf.cuni.cz.
245    10
$a Synthesis of Novel Pyrazinamide Derivatives Based on 3-Chloropyrazine-2-carboxamide and Their Antimicrobial Evaluation / $c O. Jandourek, M. Tauchman, P. Paterova, K. Konecna, L. Navratilova, V. Kubicek, O. Holas, J. Zitko, M. Dolezal,
520    9_
$a Aminodehalogenation of 3-chloropyrazine-2-carboxamide with variously substituted benzylamines yielded a series of fifteen 3-benzylaminopyrazine-2-carboxamides. Four compounds possessed in vitro whole cell activity against Mycobacterium tuberculosis H37Rv that was at least equivalent to that of the standard pyrazinamide. MIC values ranged from 6 to 42 μM. The best MIC (6 μM) was displayed by 3-[(4-methylbenzyl)amino]pyrazine-2-carboxamide (8) that also showed low cytotoxicity in the HepG2 cell line (IC50 ≥ 250 μM). Only moderate activity against Enterococcus faecalis and Staphylococcus aureus was observed. No activity was detected against any of tested fungal strains. Molecular docking with mycobacterial enoyl-ACP reductase (InhA) was performed to investigate the possible target of the prepared compounds. Active compounds shared common binding interactions of known InhAinhibitors. Antimycobacterial activity of the title compounds was compared to the previously published benzylamino-substituted pyrazines with differing substitution on the pyrazine core (carbonitrile moiety). The title series possessed comparable activity and lower cytotoxicity than molecules containing a carbonitrile group on the pyrazine ring.
650    _2
$a amidy $x chemie $7 D000577
650    _2
$a antibakteriální látky $x chemická syntéza $x farmakologie $7 D000900
650    _2
$a antiinfekční látky $x chemická syntéza $x farmakologie $7 D000890
650    _2
$a antifungální látky $x chemická syntéza $x farmakologie $7 D000935
650    _2
$a antituberkulotika $x chemická syntéza $x farmakologie $7 D000995
650    _2
$a lidé $7 D006801
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a molekulární struktura $7 D015394
650    _2
$a pyrazinamid $x chemická syntéza $x farmakologie $7 D011718
650    _2
$a pyraziny $x chemie $7 D011719
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tauchman, Marek $u Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203/8, Hradec Kralove 50005, Czech Republic. tauchmam@faf.cuni.cz.
700    1_
$a Paterova, Pavla $u Department of Clinical Microbiology, University Hospital Hradec Kralove, Sokolska 581, Hradec Kralove 50005, Czech Republic. pavla.paterova@fnhk.cz.
700    1_
$a Konecna, Klara $u Department of Biological and Medical Sciences, Teaching and Research Center of Charles University, Faculty of Pharmacy in Hradec Kralove, Charles University, Zborovska 2089, Hradec Kralove 50003, Czech Republic. konecna@faf.cuni.cz.
700    1_
$a Navratilova, Lucie $u Department of Pharmacology and Toxicology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203/8, Hradec Kralove 50005, Czech Republic. navratl2@faf.cuni.cz.
700    1_
$a Kubicek, Vladimir $u Department of Biophysics and Physical Chemistry, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203/8, Hradec Kralove 50005, Czech Republic. kubicek@faf.cuni.cz.
700    1_
$a Holas, Ondrej $u Department of Pharmaceutical Technology, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203/8, Hradec Kralove 50005, Czech Republic. holao3aa@faf.cuni.cz.
700    1_
$a Zitko, Jan $u Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203/8, Hradec Kralove 50005, Czech Republic. zitkj3aa@faf.cuni.cz.
700    1_
$a Dolezal, Martin $u Department of Pharmaceutical Chemistry and Pharmaceutical Analysis, Faculty of Pharmacy in Hradec Kralove, Charles University, Akademika Heyrovskeho 1203/8, Hradec Kralove 50005, Czech Republic. dolezalm@faf.cuni.cz.
773    0_
$w MED00180394 $t Molecules (Basel, Switzerland) $x 1420-3049 $g Roč. 22, č. 2 (2017)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28157178 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170720124642 $b ABA008
999    __
$a ok $b bmc $g 1238996 $s 984228
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 22 $c 2 $e 20170202 $i 1420-3049 $m Molecules $n Molecules $x MED00180394
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace